Post-IPO Equity - Otonomy
Investment Firm
Overview
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Announced Date
Jul 09, 2020
Closed on Date
Jul 13, 2020
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Otonomy raised $69100000 on 2020-07-09 in Post-IPO Equity
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 30, 2014 |  Series D - Otonomy | 12 | - | 49.0M |
| Sep 04, 2013 | Series C - Otonomy | 8 | - | 45.9M |
| Aug 30, 2010 | Series B - Otonomy | 4 | - | 38.5M |
| Jun 11, 2010 | Series A - Otonomy | 1 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.